Facebook
Twitter
Telegram
Report an ErrorObalon Therapeutics, Inc. Financial Statements 2011-2024 | OBLN
Annual Financial Statements Obalon Therapeutics, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
35 M | 8.41 M | 32.4 M | 73.4 M | 42.4 M | - | - | - | - | - |
Shares |
7.77 M | 4.71 M | 1.9 M | 1.67 M | 422 K | - | - | - | - | - |
Net Income |
-12.3 M | -23.7 M | -37.4 M | -34.8 M | -20.5 M | -15.6 M | -9.89 M | - | - | - |
Revenue |
1.59 M | 3.28 M | 9.1 M | 9.91 M | 3.39 M | 4.04 M | 3.54 M | - | - | - |
EBITDA |
-9.8 M | -22.3 M | -36.4 M | -34.1 M | -19.3 M | -14.8 M | -9.67 M | - | - | - |
Operating Expenses |
11.2 M | 23.6 M | 40.6 M | 39.5 M | 20.1 M | 16.5 M | 10.5 M | - | - | - |
General and Administrative Expenses |
8.78 M | 16.7 M | 29.9 M | 28.8 M | 10.2 M | - | - | - | - | - |
All numbers in USD currency